Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS Latest Infectious Disease Articles
  • Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis October 3, 2024
    Preexposure prophylaxis is emerging as an important tool to prevent HIV-1 infection. This report describes an altered presentation of acute HIV infection that may occur with use of long-acting cabotegravir PrEP.
    Raphael J. Landovitz, Sinead Delany-Moretlwe, Jessica M. Fogel, Mark A. Marzinke, Estelle Piwowar-Manning, Paul Richardson, Elias K. Halvas, John W. Mellors, Deborah Persaud, Ryan Kofron, Marybeth McCauley, Scott Rose, Alex R. Rinehart, James F. Rooney, Adeola Adeyeye, Myron S. Cohen, Deborah Donnell, Mina C. Hosseinipour, Beatriz Grinsztejn, Susan H. Eshleman, for the HPTN 083 and 084 Study Teams
  • The Real PURPOSE of PrEP — Effectiveness, Not Efficacy October 3, 2024
    Given the 40 years of research and the wealth of successful tools that have been developed to prevent, diagnose, treat, and suppress human immunodeficiency virus (HIV) infection, how is it possible that in 2024 the incidence of HIV type 1 (HIV-1) infection is more than 3.5 per 100 person-years among...
    Rochelle P. Walensky, Lindsey R. Baden
  • Chlamydial Proctitis October 3, 2024
    A 26-year-old man presented with a 1-week history of fevers and bloody stools. A CT scan of the pelvis showed rectal thickening, and a flexible sigmoidoscopy showed nodular, ulcerated mucosa.
    Kevin D. He, Judith A. O’Donnell

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.